FC
INSM icon

Fairscale Capital’s Insmed INSM Stock Holding History

Fairscale Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.94K Hold
37
– – ﹤0.01% 354
2026
Q1 		$6.05K Hold
37
– – ﹤0.01% 328
2025
Q4 		$6.44K Hold
37
– – ﹤0.01% 318
2025
Q3 		$5.33K Hold
37
– – ﹤0.01% 356
2025
Q2 		$3.97K Buy
+37
New +$2.83K ﹤0.01% 367

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Fairscale Capital's INSM Position: Q2 2026 in Review

Fairscale Capital held its Insmed (INSM) position steady in Q2 2026 at 37 shares worth $3.94K. The position accounts for ﹤0.01% of the portfolio, ranked #354.

Fairscale Capital first reported a position in INSM in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.44K in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Fairscale Capital held 37 shares of Insmed worth $3.94K as of Q2 2026.
  • Fairscale Capital left its Insmed share count unchanged in Q2 2026.
  • Insmed made up ﹤0.01% of Fairscale Capital's portfolio in Q2 2026, its #354 holding.
  • Fairscale Capital first reported a position in Insmed in Q2 2025 and has held it in 5 quarters since.
  • Fairscale Capital's Insmed position peaked at $6.44K in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.